Juni 6, 2024 | H&P News, M&A
BÜHLMANN Laboratories AG from Schönenbuch announces the completion of the acquisition by KLAR Partners Limited. Thanks to the acquisition, the company’s future is in safe hands. The strong global market positions of the BÜHLMANN Group will be further expanded. Since...
Apr. 30, 2024 | CFO-Services, H&P News, M&A
Der Swiss Biotech Day in Basel war eine wunderbare Gelegenheit, viele inspirierende Menschen zu treffen, die sich den Biowissenschaften und der Biotechnologie verschrieben haben und sich mit ihnen auszutauschen. Werfen Sie einen Blick in das Video-Interview, um mehr...
Apr. 4, 2024 | H&P News, M&A
Within the DACH region, the number of transactions in the Health Care industry declined by 24% between 2022 and 2023. Switzerland, however, keeps developing positively and remains on a constant level when it comes to the number of transactions. In the following...
Feb. 26, 2024 | CFO-Services, Corporate Finance, H&P News, M&A
Der Aufstieg der Schweiz zum Zentrum für Start-ups im Bereich der Lebenswissenschaften ist eng mit dem wachsenden Ökosystem der Biotech-, Medtech- und Nanotech-Unternehmen verbunden. Dieses florierende Ökosystem profitiert von erheblichen Investitionen in Forschung...
Dez. 12, 2023 | H&P News, M&A
Predictive Layer, the Swiss provider of forecasting solutions in the energy and commodity trading sector, was sold to TotalEnergies. Hoffmann & Partner acted as the exclusive financial advisor to the sellers. TotalEnergies will improve the performance of its...
Nov. 30, 2023 | H&P News, M&A
We advised Stille, a listed Swedish medtech company, in the acquisition of Fehling Instruments based in Germany in a joint mandate with our AICA network partner Evli Corporate Finance. Through the acquisition, Stille significantly broadens its product offering of...
